ISRCTN95900937进行中（未招募）Unknown
VidPrevtyn Beta® vaccine effectiveness against hospitalization due to SARS-CoV-2 infection – a secondary database study in the UK
Sanofi (France)0 个研究点目标入组 617,000 人开始时间: 2023年7月24日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 617,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •This study will include all individuals aged 18 years or older who are eligible to receive a VidPrevtyn Beta vaccine.
排除标准
- •Individuals <18 years and those who are ineligible to receive a VidPrevtyn Beta vaccine.
研究者
相似试验
已完成
不适用
Comparing accelerated vs. classic vaccination protocols regarding the efficacy of hepatitis B vaccination in prisonersACTRN12610000726055Kamran B Lankarani180
已完成
不适用
The Efficacy of Hepatitis B Virus (HBV) Vaccination in Patients with Previously Resolved HBV Infection Receiving Immunosuppressive Therapy to Prevent HBV Reactivation through Increase of Serum Levels of Anti-HBs (Pilot Study)Collagen disease, collagen disease related disease, ulcerative colitis, Crohn's disease, intestinal Behcet's disease (simple ulcers included), psoriasis, and diseases that require other immunosuppressive therapies.JPRN-UMIN000042288Saitama Medical University13
进行中（未招募）
不适用
Evaluation of the effectiveness of vaccination with 2009 H1N1 vaccines during influenza season 2010-112009 H1N1-influenssarokotteiden tehokkuus influenssakaudella 2010-11 - Pandemiarokotuskampanjan jatkotutkimusInfluenza caused by the 2009 H1N1 influenza virus (swine influenza)MedDRA version: 12.1Level: LLTClassification code 10022001Term: Influenza (epidemic)EUCTR2010-021033-30-FIational Institute for Health and Welfare3,000
已完成
不适用
Safety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in GermanySafety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in GermanyB04MonkeypoxDRKS00029638Charité - Universitätsmedizin Berlin15,813
招募中
不适用
Covaxin Vaccination Effectiveness in Children and Adolescents in IndiaCTRI/2022/09/045840Bharat Biotech International Limited BBI